FSMAX
Price
$94.94
Change
+$0.66 (+0.70%)
Updated
Nov 8 closing price
JDERX
Price
$13.64
Change
+$0.03 (+0.22%)
Updated
Nov 8 closing price
Ad is loading...

FSMAX vs JDERX

Header iconFSMAX vs JDERX Comparison
Open Charts FSMAX vs JDERXBanner chart's image
Fidelity Extended Market Index
Price$94.94
Change+$0.66 (+0.70%)
VolumeN/A
CapitalizationN/A
PGIM Jennison Mid-Cap Growth R
Price$13.64
Change+$0.03 (+0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMAX vs JDERX Comparison Chart
Loading...
VS
FSMAX vs. JDERX commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and JDERX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. JDERX (2.65B). FSMAX pays higher dividends than JDERX: FSMAX (1.10) vs JDERX (0.00). FSMAX was incepted earlier than JDERX: FSMAX (13 years) vs JDERX (19 years). JDERX is a more actively managed with annual turnover of: 38.00 vs. FSMAX (18.00). FSMAX (0) and JDERX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 45.37 vs. JDERX (25.95). FSMAX return over 5 years is better than : 56.24 vs. JDERX (-51.16).
FSMAXJDERXFSMAX / JDERX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years19 years-
Gain YTD21.62415.398140%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40B2.65B1,511%
Annual Yield % from dividends1.100.00-
Returns for 1 year45.3725.95175%
Returns for 3 years2.38-37.66-6%
Returns for 5 years56.24-51.16-110%
Returns for 10 years86.33-66.64-130%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHR3.390.27
+8.65%
Braemar Hotels & Resorts
ATAT26.55-0.15
-0.56%
Atour Lifestyle Holdings Limited
EFSH0.24N/A
-0.95%
1847 Holdings LLC
RPRX26.21-0.31
-1.17%
Royalty Pharma plc
FLGT19.43-2.59
-11.76%
Fulgent Genetics